Data / Form D filings / Kadmon Holdings, LLC
Kadmon Holdings, LLC: Form D filings
Kadmon Holdings, LLC, a biotechnology company in New York, NY, filed 2 Form D notices with the SEC between 2012 and 2014. The latest, on July 31, 2014, reports $5.7 million sold of a $50 million offering to 3 investors.
Find out what Kadmon Holdings, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 450 EAST 29TH STREET, New York, NY, 10016
- Phone
- (212) 308-6000
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1557142
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2014 | New notice | $50,000,000 | $5,690,000 | $44,310,000 | 3 | Jul 25, 2014 | sec.gov |
| Aug 30, 2012 | New notice | $50,000,000 | $4,744,220 | $45,255,780 | 3 | Aug 23, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Larry D Witte | Executive Officer | |
| Andrew D Cohen | Director | |
| Steven N Gordon | Executive Officer | |
| Eugene D Bauer | Director | |
| Dixon D Boardman | Director | |
| Susan D Wiviott | Director | |
| Thomas D Shenk | Director | |
| Harlan D Waksal | Director | |
| Zhenping D Zhu | Executive Officer | |
| Samuel D Waksal | Executive Officer, Director | |
| Adriann D Sax | Executive Officer | |
| Alexandria D Forbes | Director | |
| Louis Shengda D Zan | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jul 28, 2014 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kadmon Holdings, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.